Biotech Values

[dewophile]

and yet we have someone "normal" appointed to head FDA
You can argue that this is because they have to pass senate confirmation, but I don't think the incoming FDA head is on board w just anyone at CBER or CDER. Let's see what happens now that Makary is about to be sworn in. Here is a Forbes piece arguing his agenda may be to accelerate drug approvals:

https://www.forbes.com/sites/sallypipes/2025/03/31/heres-how-trumps-pick-to-lead-the-fda-can-supercharge-the-agency/

The vaccine story remains troubling of course, but if you can point me to a very depressed pure play vaccine company I would consider investing (MNTA BNTX have too much other baggage). I don't think significantly fewer folks are truly going to stop getting their vaccinations, but new approvals could be more challenging in certain select areas (e.g. mrna flu where older platforms w decades of safety exist)